RELIANCE: Moringa in Lactation and Early Childhood
Part of paid clinical trials in Brooklyn, New York.
- Sponsor
- Philip Kern
- Study ID
- NCT07605091
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Breast Feeding
- Lactation
Eligibility Criteria
- Sex
- FEMALE
- Age
- 7 Days - 99 Years
- Healthy Volunteers
- Accepted
Interventions
- Moringa Leaf Powder — DIETARY_SUPPLEMENTParticipants randomized to Moringa will consume 10 grams each day of the Moringa leaf powder mixed into porridge.
- Carrier — OTHERParticipants randomized to the control will be given porridge without Moringa.
Study Details
This study will assess the impact of maternal moringa supplementation to mothers of breastfeeding infants on milk output, milk composition, exclusive breastfeeding duration, and maternal and child health. This will be accomplish by conducting a randomized, controlled dietary intervention study enrolling breastfeeding mothers and their newborn infants. Mothers will be randomized to receive either 10g dried moringa leaf powder in carrier vs. carrier alone, consumed daily for four months, with follow-up for 2 years. Women must be \>18 years of age, ≤ 30 days postpartum and exclusively breastfeeding at the time of enrollment. Infants must be at least 37 weeks of gestational age, be healthy and are able to feed orally and consume human milk. After randomization and enrollment, breast milk samples will be obtained at baseline, 2, 4, and 6 months. Serum from mothers will be collected at recruitment, 2, 6,and 9 months; infant serum will be collected by capillary sample at recruitment and approximately at 4, 6, 12, 18, and 24 months. Infant hemoglobin and infant feeding weights (test weights) will be collected on sequential days at recruitment, 4, and 6 months. 24-hour dietary recall: the foods and drinks consumed by mothers in the 24 hours prior to each milk sample. Other assessments will include perceptions of breastfeeding, assess complementary feeding practices. Review will be conducted of maternal and infant infections, diagnoses, and hospitalizations at the time of visit or since the last visit.
Key Dates
- Start date
- Nov 30, 2026
- Status verified
- May 2026
- Primary completion
- Sep 30, 2029
- Completion
- Jun 30, 2030
Study Design
- Enrollment
- 100 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Carrier and Moringa Leaf Powder
- Placebo Comparator: Carrier
Primary Outcome Measure
Maternal Serum Levels of Estradiol [ Time Frame: Baseline, 2 months, 4 months, 6 months and 9 months ]
Central Contacts
- Philip Kern8593232615
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| SUNDY Downstate | Brooklyn | New York | 11203 | - |
Find similar trials in Brooklyn, NY
Related Studies
- At-the-Breast vs. Expressed Human Milk: Genesis of Infant Nutrition (BEGIN)Recruiting · University of Rochester · Rochester, New York
- A Study to Measure Mirikizumab Levels in Breast Milk of Lactating Participants Receiving Mirikizumab Therapeutically for an Approved IndicationPHASE4 · Not Yet Recruiting · Eli Lilly and Company · Glenview, Illinois
- Drug Excretion in Breast MilkPHASE4 · Recruiting · University of Washington · Seattle, Washington
- Developmental Impacts of Microplastics Exposure in Early LifeRecruiting · Johns Hopkins Bloomberg School of Public Health · Baltimore, Maryland